CVR number 34888604
Industry 32.5000 Manufacture of medical and dental instruments and supplies

TANDPROTETIKEREN HJØRRING ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  6.1% 4.8% 4.1% 4.4% 3.0%  
Credit score (0-100)  38 44 48 46 57  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,692 1,686 1,771 2,575 2,561  
EBITDA  630 673 373 760 687  
EBIT  489 526 192 633 602  
Pre-tax profit (PTP)  444.2 494.3 169.1 624.3 596.7  
Net earnings  345.5 385.8 134.3 487.8 465.3  
Pre-tax profit without non-rec. items  444 494 169 624 597  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  362 427 551 424 340  
Shareholders equity total  102 487 372 860 925  
Interest-bearing liabilities  727 371 451 0.0 0.0  
Balance sheet total (assets)  1,098 1,222 1,090 1,301 1,248  
Net Debt  561 145 450 -291 -487  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,692 1,686 1,771 2,575 2,561  
Gross profit growth  55.6% -0.3% 5.0% 45.4% -0.5%  
Employees  3 3 3 4 4  
Employee growth %  -25.0% 0.0% 0.0% 33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,098 1,222 1,090 1,301 1,248  
Balance sheet change%  1.6% 11.2% -10.8% 19.4% -4.1%  
Added value  630.0 673.2 372.9 814.1 687.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -204 -82 -56 -253 -170  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  28.9% 31.2% 10.9% 24.6% 23.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  40.4% 45.4% 16.7% 53.3% 47.4%  
ROI %  47.6% 60.0% 22.8% 74.7% 66.2%  
ROE %  58.4% 131.0% 31.3% 79.2% 52.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  9.4% 39.9% 34.1% 66.1% 74.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  89.1% 21.5% 120.5% -38.3% -70.9%  
Gearing %  714.7% 76.0% 121.4% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 5.9% 5.8% 5.5% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.5 1.2 0.5 1.5 2.3  
Current Ratio  1.8 1.4 0.8 1.9 2.8  
Cash and cash equivalent  165.3 225.8 1.8 290.9 487.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  299.4 215.1 -93.1 385.1 542.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  210 224 124 204 172  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  210 224 124 190 172  
EBIT / employee  163 175 64 158 151  
Net earnings / employee  115 129 45 122 116